| Issue Date | Title | Author(s) |
| Jul-2021 | CHESS criteria for screening and monitoring of varices needing treatment: an international multicenter study | Liu, Chuan; Li, Jia; Zeng, Qing-Lei; You, Hong; Ji, Dong; Wong, Yu Jun; Gu, Ye; Zhang, Guo; Bu, Yang; Wang, Fengmei; Wei, Qin; Zhao, Lili; Li, Shuang; Wang, Yan; Li, Musong; Hu, Shengjuan; Wu, Xiaoli; Bao, Jinlun; Xin, Yongning; Hu, Doudou; Jiang, Zicheng; Chi, Xiaoling; Zhang, Yong; Pu, Chunwen; Lu, Ming; Li, Li; He, Qibin; Ma, Deqiang; He, Yuqian; Zhang, Mingxin; Liu, Huan; Liu, Chao; Yang, Li; He, Chaohui; Tang, Shanghong; Wang, ChunYan; Wang, Wenjuan; Hua, Peng; Zhang, Liting; Zheng, Ming-Hua; Liu, Dengxiang; Zhaoxi, Pingcuo; Yang, Xiaosong; Yangzhen, Bianba; Mao, Fuji; Song, Chuan; Ao, Jiafu; Zhao, Taiyun; Gao, Youfang; Hu, Hao; Wu, Jun; Li, Tinghong; Xiang Huiling; Cao, Zhujun; Qi, Hailong; Zhou, Shengqiang; Ge, Guohong; Shao, Jianbo; Wang, Bingqiong; Li, Ping; Han, Tao; Li, Lei; Li, Minghui; Xie, Wen; Jiang, Wei; Xu, Mingyi; Feng, Bo; Chen, Jilin; Wang, Xiaozhong; Li, Hai; Piao, Hongxin; Ji, Jiansong; Shao, Chuxiao; Dang, Tong; Zhou, Yi; Tang, Juan; He, Guochang; Dong, Li; Li, Jun; Zhou, Xiqiao; Zhang, Guoxin; The, Kok Ban; Tong, Jing; Yi, Yiling; Chen, Liang; Xie, Qing; Rockey, Don; Dong, Jiahong; Qi, Xiaolong |
| Nov-2021 | Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition) | Sun, Hui-Chuan; Zhou, Jian; Wang, Zheng; Liu, Xiufeng; Xie, Qing; Jia, Weidong; Zhao, Ming; Bi, Xinyu; Li, Gong; Bai, Xueli; Ji, Yuan; Xu, Li; Zhu, Xiao-Dong; Bai, Dousheng; Chen, Yajin; Chen, Yongjun; Dai, Chaoliu; Guo, Rongping; Guo, Wenzhi; Hao, Chunyi; Huang, Tao; Huang, Zhiyong; Li, Deyu; Li, Gang; Li, Tao; Li, Xiangcheng; Liang, Xiao; Liu, Jingfeng; Liu, Fubao; Lu, Shichun; Lu, Zheng; Lv, Weifu; Mao, Yilei; Shao, Guoliang; Shi, Yinghong; Song, Tianqiang; Tan, Guang; Tang, Yunqiang; Tao, Kaishan; Wan, Chidan; Wang, Guangyi; Wang, Lu; Wang, Shunxiang; Wen, Tianfu; Xing, Baocai; Xiang, Bangde; Yan, Sheng; Yang, Dinghua; Yin, Guowen; Yin, Tao; Yin, Zhenyu; Yu, Zhengping; Zhang, Bixiang; Zhang, Jialin; Zhang, Shuijun; Zhang, Ti; Zhang, Yamin; Zhang, Yubao; Zhang, Aibin; Zhao, Haitao; Zhou, Ledu; Zhang, Wu; Zhu, Zhenyu; Qin, Shukui; Shen, Feng; Cai, Xiujun; Teng, Gaojun; Cai, Jianqiang; Chen, Minshan; Li, Qiang; Liu, Lianxin; Wang, Weilin; Liang, Tingbo; Dong, Jiahong; Chen, Xiaoping; Wang, Xuehao; Zheng, Shusen; Fan, Jia |
| 2019 | Cirrhotic stiffness affects the migration of hepatocellular carcinoma cells and induces sorafenib resistance through YAP | Gao, Jian; Rong, Yingxue; Huang, Yuxing; Shi, Peng; Wang, Xitao; Meng, Xuan; Dong, Jiahong; Wu, Congying |
| 2008 | Comparison of four current staging systems for Chinese patients with hepatocellular carcinoma undergoing curative resection: Okuda, CLIP, TNM and CUPI | Lu, Wenping; Dong, Jiahong; Huang, Zhiqiang; Guo, Deyu; Liu, Yousheng; Shi, Shuang |
| Feb-2020 | CXCR2-modified CAR-T cells have enhanced trafficking ability that improves treatment of hepatocellular carcinoma | Liu, Guangna; Rui, Wei; Zheng, Hongli; Huang, Daosheng; Yu, Fei; Zhang, Yuewei; Dong, Jiahong; Zhao, Xueqiang; Lin, Xin |
| May-2020 | CXCR2-modified CAR-T cells have enhanced trafficking ability that improves treatment of hepatocellular carcinoma | Liu, Guangna; Rui, Wei; Zheng, Hongli; Huang, Daosheng; Yu, Fei; Zhang, Yuewei; Dong, Jiahong; Zhao, Xueqiang; Lin, Xin |
| 17-Mar-2025 | Disparities in the incidence, mortality and disability-adjusted life years of 33 early-onset cancer groups globally, 2012-2021: a systematic analysis | Yan, Wenxin; Liu, Min; Jing, Wenzhan; Kang, Liangyu; Zhang, Ning; Sun, Haoran; He, Jinyu; Chen, Zhongdan; Liu, Jue; Liang, Wannian; Dong, Jiahong |
| 1-May-2024 | NIR-II light in clinical oncology: opportunities and challenges | Zhang, Zeyu; Du, Yang; Shi, Xiaojing; Wang, Kun; Qu, Qiaojun; Liang, Qian; Ma, Xiaopeng; He, Kunshan; Chi, Chongwei; Tang, Jianqiang; Liu, Bo; Ji, Jiafu; Wang, Jun; Dong, Jiahong; Hu, Zhenhua; Tian, Jie |
| 2018 | Quantified postsurgical small cell size CFCs and EpCAM(+) circulating tumor stem cells with cytogenetic abnormalities in hepatocellular carcinoma patients determine cancer relapse | Wang, Liang; Li, Yilin; Xu, Jing; Zhang, Aiqun; Wang, Xuedong; Tang, Rui; Zhang, Xinjing; Yin, Hongfang; Liu, Manting; Wang, Daisy Dandan; Lin, Peter Ping; Shen, Lin; Dong, Jiahong |
| 2016 | RPL23 Links Oncogenic RAS Signaling to p53-Mediated Tumor Suppression | Meng, Xuan; Tackmann, Nicole R.; Liu, Shijie; Yang, Jing; Dong, Jiahong; Wu, Congying; Cox, Adrienne D.; Zhang, Yanping |
